Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Scleroderma Patient-centered Intervention Network (SPIN) Self-Management Program: Protocol for a Randomised Controlled Feasibility Trial With Progression to Full-Scale Trial

NCT04246528 is registered in ClinicalTrials.gov with Lady Davis Institute as lead sponsor.

NCT NCT04246528
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04246528 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Scleroderma Patient-centered Intervention Network (SPIN) Self-Management Program: Protocol for a Randomised Controlled Feasibility Trial With Progression to Full-Scale Trial
Lead sponsor
Lady Davis Institute
Phase
Not applicable
Overall status
Completed
Start date
September 15, 2021
Completion date
May 1, 2025
Enrollment
169 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

scleroderma, systemic sclerosis